Swedish pharma exports on the riseExports of pharmaceuticals reached a peak of SEK 152.5 billion, which corresponds to 7.3 percent of Sweden's total export value, and means an almost 10 percent increase since 2022. Swedish pharmaceutical exports are of growing importance to the economy and are today significantly larger than, for example, exports of iron and steel.
The statistics also indicate that the Swedish life science industry is consolidating its position as a significant player on the global market, both in terms of the innovation that takes place here and the export of high-quality products it generates.
Demand for Swedish pharmaceutical products is strong internationally and the growth in pharmaceutical exports is a result of the industry's continued investment in innovation and quality, which has resulted in products that are appreciated and in demand globally.
The increasing export value of Swedish pharmaceuticals underlines the importance of the industry for the national economy. The export successes contribute to strengthening Sweden's position as a leading player in life science and provide positive effects for both the industry and the country's economy.
With a continued focus on innovation, quality and global cooperation, Swedish pharmaceutical exports are expected to continue their positive development. This not only provides opportunities for the industry to grow and develop, but also for Sweden to continue to play a prominent role in the global life science sector.
About SwedenBIO
The industry organization SwedenBIO works for a competitive life science sector in Sweden. We do this by creating effective interfaces between the sector's various actors, by building knowledge and by giving the industry a strong voice in the public debate. Our more than 330 member companies are active in drug development, biotechnology, medical technology and diagnostics or are experts in business development, financing, intellectual property and law.
Powered by Notified